Background: In Saudi Arabia, sickle-cell disease is among the most prevalent
hematologic hereditary illnesses. In SCD patients, vascular-occlusive pain crises
are a common reason for emergency room visits, and patients' suffering may go
untreated. This research offers a systematic literature review of the current
treatments for acute pain crises in SCD patients. Method: The authors examined
five scientific databases—MEDLINE, PubMed, CENTRAL, CINAHL, and Web of
Science—to locate published works through 2023. For every database, a
comprehensive search strategy was developed using MeSH keywords. The
phrases opioids, anemia, sickle cell, double-blinded, randomized controlled
study, acute pain, and clinical trial are used. Results: Six full-text articles with 424
patients were included for our review out of the 201 articles initially gathered
from databases. Duplication was removed, and the articles were assessed against
inclusion criteria. Of the included studies, three were conducted in the United
States, one in Connecticut, one in Maryland, and one in Canada. Using guidelines
for higher opioid doses for acute painful episodes in SCD patients was related to
better pain outcomes and fewer hospitalizations. According to current standards,
patients with SCD should get opioid analgesia within 30 minutes of being
triaged. Conclusion: Almost all SCD patients who were hospitalized as a result of
acute pain were provided opioids; there's no set method in strict accordance with
guidelines from the Centers for Disease Control and Prevention.
Keywords: Sickle cell disease, acute pain, emergency department, opioid